XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.1
(5) Share-Based Payments
3 Months Ended
Mar. 27, 2021
Share-based Payment Arrangement [Abstract]  
(5) Share-Based Payments

(5)       Share-Based Payments

 

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

 

During the quarters ended March 27, 2021 and March 28, 2020 a total of 200,000 and 59,000 stock options, respectively, were granted to employees under the Company’s 2020 Equity Incentive Plan (the “Plan”) and a total of 0 and 60,000 stock options, respectively, were granted to outside directors during the quarters ended March 27, 2021 and March 28, 2020.

 

During the quarter ended March 27, 2021 there were 613,800 options exercised and corresponding shares   issued at a weighted average price of $1.98  . During the quarter ended March 28, 2020 there were no shares exercised or issued.

 

During the quarter ended March 27, 2021, the Company repurchased 120,196 shares   for employees to facilitate their exercise of stock options. During the quarter ended March 28, 2020 there were no shares repurchased.

 

There were also 837,700 shares outstanding at a weighted average price of $1.92 with a weighted average remaining term of 6.74 years as of March 27, 2021, and there were 450,100 shares exercisable at a weighted average price of $1.74 with a weighted average remaining term of 4.92 years as of March 28, 2020. The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As of March 27, 2021, there were 1,186,000 shares available for future grants.

 

As of March 27, 2021, there was $391 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 1.79 years.

 

During the quarters ended March 27, 2021 and March 28, 2020, the Company recognized approximately $27 thousand and $66 thousand, respectively, as shared-based compensation expense related to previously granted shares under the Plan.